Table 2. Nicotine administration studies in people with schizophrenia that measure cognition.
Nicotine Ad- ministration |
Dose (mg) or Administration |
Duration | Design | Smokers | Antipsychotics | Enrolled | Cognitive Battery |
Results of Nicotine (N) Compared to Placebo (P) or Con- trol (C) Condition |
|
---|---|---|---|---|---|---|---|---|---|
Levin 1996 | Patch | 7, 14, 21 | 4 days | Placebo Crossover |
100% | Haloperidol (titrated to low, medium, and how doses) |
15 | ANAM (DMS, RT, SMT, SPRT), CPT |
SPRT: N > P, DMS: N > P, CPT: N > P (On all tasks interaction with nicotine dose and haloperidol dose) |
Smith 2002 | Cigarettes/Nasal | 3-6 cigarettes / 50% 6 sprays (L) 50% 12 sprays (H) |
4 days | Placebo Crossover |
100% | 1st and 2nd Gen- eration |
31 | ANAM (DMS, RT, SMT, SPRT), RMT (5-items, DS, PW, SS), VF |
SPRT: Cigarettes, Nasal > P RT: H Nasal > P PW, SS: Nasal > P |
*Sherr 2002 |
Nasal | 2 sprays | 2 days | Crossover | 52% | 1st and 2nd Gen- eration |
29 | CPT | N = C |
*Depatie 2002 |
Patch | 14 | 2 days | Placebo Crossover |
100% | 1st and 2nd Generation | 15 | CPT | CPT: N > P |
*Myers 2004 |
Nasal | 6 sprays | 2 days | Crossover | 52% | 1st and 2nd Gen- eration |
29 | DMS, DRT | DRT: (Smokers) N > control |
*Jacobson 2004 |
Patch | 28 or 35 Weight based |
2 days | Placebo Crossover |
100% | 1st and 2nd Gen- eration |
13 | SAL, VWM | VWM: N > P |
Harris 2004 |
Gum | 6 | 2 days | Placebo Crossover |
50% | 1st and 2nd Gen- eration |
20 | RBANS | Attention: (Non- Smokers) N > control |
Smith 2005 | Nasal | 8 sprays | 4 days | Placebo Crossover |
100% | 1st and 2nd Gen- eration |
27 | ANAM (SPRT), CPT, DMT, RANDT MS |
CPT, DMT: N > P |
*Barr 2007 | Patch | 14 | 2 days | Placebo Crossover |
0% | 1st and 2nd Gen- eration |
28 | CPT, GP, LNS, ST |
CPT, ST: N > P |
*Jubelt 2008 |
Patch | 14 | 2 days | Placebo Crossover |
0% | 1st and 2nd Gen- eration |
10 | EMP | EMP: N > P |
*Hong 2011 |
Patch | 21 or 35 based on cigarette use |
2 days | Placebo Crossover |
100% | 1st and 2nd Gen- eration |
20 | RVIP | RVIP: N > P |
Hahn 2013 | Cigarettes/Patch | Ad libitum/14 | 3 days | Placebo Crossover |
100% | 1st and 2nd Gen- eration |
17 | SARAT, SDT |
SARAT: Patch > P SDT: Patch, Cigarettes > P |
ANAM: Neuropsychological Assessment Metrics, CPT: Continuous Performance Test, CRT: Complex Reaction Time, DMS: Delayed Matching to Sample, DMT: Dot Memory Test, DRT: Delayed Recognition, DS: Digit Span, EMP: Episodic Memory Paradigm, GP: Grooved Pegboard, LNS: Letter Number Sequence, MS: Memory Scale, N: Nicotine, P: Placebo, PW: Paired Words, RBANS: Repeatable Battery for the Assessment of Neuropsychological Status, RMT: Randt Memory test, RT: Reaction Time, RVIP: Rapid Visual Information Processing, SAL: Selective Attention Load, SARAT: Spatial Attentional Resource Allocation Task, SDT: Singleton Detection Task, SMT: Sternberg Memory Test, SPRT: Spatial Rotation Task, SS: Short Story, ST: Stroop Test, VSWM: Visuospatial Working Memory, VWM: Verbal Working Memory, WCST: Wisconsin Card Sorting Test, WSPT: Word Serial Position Test
Healthy controls enrolled but results only on schizophrenia cohort